MyAverix Finance
SHG · Healthcare
Jiangsu Bioperfectus Technologies Co Ltd (688399)
Biotechnology
Jiangsu Bioperfectus Technologies Co Ltd (688399) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $4.66B, P/E ratio is 18.00, net margin is -11.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688399
Jiangsu Bioperfectus Technologies Co Ltd (688399) — FAQ
What is Jiangsu Bioperfectus Technologies Co Ltd's market cap?
Jiangsu Bioperfectus Technologies Co Ltd (688399) has a reported market cap of $4.66B (data as of 2026-03-29).
What is 688399's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu Bioperfectus Technologies Co Ltd (688399) is 18.00 (data as of 2026-03-29).
Does Jiangsu Bioperfectus Technologies Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu Bioperfectus Technologies Co Ltd (688399). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu Bioperfectus Technologies Co Ltd in?
Jiangsu Bioperfectus Technologies Co Ltd (688399) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688399 listed on?
688399 is listed on SHG.
What is Jiangsu Bioperfectus Technologies Co Ltd's net margin?
Jiangsu Bioperfectus Technologies Co Ltd (688399) reports a net margin of -11.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.